Legal Representation
Attorney
THOMAS M. PALISI
USPTO Deadlines
Next Deadline
247 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2020-04-07)
Due Date
April 07, 2026
Grace Period Ends
October 07, 2026
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
37 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Apr 7, 2025 | REM1 | E | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | Loading... |
| Feb 11, 2022 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
| Feb 11, 2022 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Feb 11, 2022 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Feb 11, 2022 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
| Feb 11, 2022 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Apr 7, 2020 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Mar 5, 2020 | SUNA | E | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | Loading... |
| Mar 4, 2020 | CNPR | P | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | Loading... |
| Mar 3, 2020 | SUPC | I | STATEMENT OF USE PROCESSING COMPLETE | Loading... |
| Mar 2, 2020 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Feb 10, 2020 | IUAF | S | USE AMENDMENT FILED | Loading... |
| Feb 10, 2020 | EISU | I | TEAS STATEMENT OF USE RECEIVED | Loading... |
| Aug 3, 2019 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Aug 1, 2019 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
| Aug 1, 2019 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Aug 1, 2019 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
| Jul 30, 2019 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Jul 30, 2019 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Jan 31, 2019 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Jan 29, 2019 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Jan 29, 2019 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Jan 29, 2019 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Sep 26, 2018 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Sep 26, 2018 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Jul 13, 2018 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Jul 11, 2018 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jul 11, 2018 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Jul 11, 2018 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Feb 13, 2018 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Dec 19, 2017 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Dec 19, 2017 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Nov 29, 2017 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Nov 16, 2017 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Nov 14, 2017 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Aug 18, 2017 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Aug 15, 2017 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 042
Scientific research and development services for direct cloning and screening T-cell receptors from single T-cells for desired specificities such as anti-tumor or anti-minor histocompatibility antigens, and transducing them into primary T-cells for therapeutic use
First Use Anywhere:
Jul 29, 2019
First Use in Commerce:
Jul 29, 2019
Class 044
Medical treatment services, namely, the administration of gene therapy to patients involving harvesting a patient's cells, cloning their T-cell receptors from single cells, screening these receptors for desired specificities such as anti-tumor or anti-minor histocompatibility antigens, transducing them into primary T-cells, and re-administration of the transduced T-cells back into the patient
First Use Anywhere:
Jul 29, 2019
First Use in Commerce:
Jul 29, 2019
Additional Information
Pseudo Mark
TCX PRESS
Classification
International Classes
042
044